Clinical Utility of Azacitidine in the Management of Acute Myeloid Leukemia: Update on Patient Selection and Reported Outcomes.

Publication Year: 2022

DOI:
10.2147/CMAR.S271442

PMCID:
PMC9793740

PMID:
36583031

Journal Information

Full Title: Cancer Manag Res

Abbreviation: Cancer Manag Res

Country: Unknown

Publisher: Unknown

Language: N/A

Publication Details

Subject Category: Oncology

Available in Europe PMC: Yes

Available in PMC: Yes

PDF Available: No

Transparency Score
3/6
50.0% Transparent
Transparency Indicators
Click on green indicators to view evidence text
Core Indicators
Data Sharing
Code Sharing
Evidence found in paper:

"Disclosure TB received a Mayo Clinic Cancer Center Research Support Grant (grant number P30 CA015083). The authors report no other conflicts of interest in this work."

Evidence found in paper:

"Disclosure: TB received a Mayo Clinic Cancer Center Research Support Grant (grant number P30 CA015083). The authors report no other conflicts of interest in this work."

Protocol Registration
Open Access
Paper is freely available to read
Additional Indicators
Replication
Novelty Statement
Assessment Info

Tool: rtransparent

OST Version: N/A

Last Updated: Aug 05, 2025